The purpose of the Administration Core is to support the translational research objectives of the UCLA SPORE in Prostate Cancer by serving as the organizational hub. The Core is responsible for the oversight of our SPORE by providing scientific leadership and administration for the proposed translational research projects, shared core resources. Developmental Research (DRP) and Career Development Programs (CDP). The overall Specific Aims are: 1) Organizational leadership for successful SPORE conduct;2) Oversight and administrative support for daily SPORE activities;3) Scientific management of the SPORE, including scientific review of projects and cores to ensure scientific goals are met;4) Administration of the DRP and CDP;5) Responsibility for maintaining fiscal and budgetary functions;6) Organization and conduct of regular SPORE meetings and seminars. Including the Annual UCLA SPORE in Prostate Cancer Symposium, quarterly investigator meetings, attendance at the NCI Translational Science meeting and relevant NIH/NCI workshops;7) Compliance with all UCLA, NCI, and Federal regulations and requirements including appropriate animal subject approval maintenance, appropriate human subject approval maintenance, and minority inclusion policy monitoring;8) A Data/Resource Sharing Plan implemented by project and core investigators;9) Liaison service for SPORE investigators, collaborators, and committee members, including the External Advisory Board (EAB), Internal Advisory Board (IAB), Executive Committee and Patient Advocacy Group, and responsibility for communication and consultation with the NCI-TRP program officer and staff;10) Implement and monitor recommendations of the External Advisory Committee, Internal Advisory Board, Executive Committee, CDP and DRP committees within the SPORE. The Administration Core is led by Robert Reiter, MD, the SPORE principal investigator, who oversees all SPORE activities. The Core's co-director is Owen Witte, MD. The Administration Core also includes expert personnel in general university operations, grants administration, financial management, computer network support and general administrative duties.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA092131-12
Application #
8760362
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
12
Fiscal Year
2014
Total Cost
$179,159
Indirect Cost
$75,313
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chen, Changhao; Cai, Qingqing; He, Wang et al. (2016) An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer. Int J Cancer 138:74-86
Yan, Yunwen; Li, Zhen; Xu, Xiang et al. (2016) All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy. BMC Complement Altern Med 16:113
Hurley, Paula J; Sundi, Debasish; Shinder, Brian et al. (2016) Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res 22:448-58
Faltermeier, Claire M; Drake, Justin M; Clark, Peter M et al. (2016) Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A 113:E172-81
Liang, Pei; Henning, Susanne M; Schokrpur, Shiruyeh et al. (2016) Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression. Prostate 76:1293-302
Lee, John K; Phillips, John W; Smith, Bryan A et al. (2016) N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell 29:536-47
Wang, Piwen; Henning, Susanne M; Magyar, Clara E et al. (2016) Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy. J Exp Clin Cancer Res 35:73
Hu, Yangyang; Dong, Xuecheng; Wang, Guangchun et al. (2016) Five-Year Follow-Up Study of Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia. J Endourol 30:97-101
Park, Jung Wook; Lee, John K; Phillips, John W et al. (2016) Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proc Natl Acad Sci U S A 113:4482-7
Stoyanova, Tanya; Riedinger, Mireille; Lin, Shu et al. (2016) Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A 113:E6457-E6466

Showing the most recent 10 out of 279 publications